Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Whitehawk Therapeutics (WHWK) Interest & Investment Income: 2018-2025

Historic Interest & Investment Income for Whitehawk Therapeutics (WHWK) over the last 5 years, with Sep 2025 value amounting to $1.9 million.

  • Whitehawk Therapeutics' Interest & Investment Income rose 104.19% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.3 million, marking a year-over-year increase of 11.52%. This contributed to the annual value of $3.9 million for FY2024, which is 38.67% down from last year.
  • According to the latest figures from Q3 2025, Whitehawk Therapeutics' Interest & Investment Income is $1.9 million, which was down 6.52% from $2.0 million recorded in Q2 2025.
  • Whitehawk Therapeutics' 5-year Interest & Investment Income high stood at $2.0 million for Q2 2025, and its period low was $12,000 during Q4 2021.
  • For the 3-year period, Whitehawk Therapeutics' Interest & Investment Income averaged around $1.4 million, with its median value being $1.5 million (2023).
  • In the last 5 years, Whitehawk Therapeutics' Interest & Investment Income soared by 13,291.67% in 2022 and then slumped by 54.93% in 2024.
  • Over the past 5 years, Whitehawk Therapeutics' Interest & Investment Income (Quarterly) stood at $12,000 in 2021, then soared by 13,291.67% to $1.6 million in 2022, then declined by 6.66% to $1.5 million in 2023, then tumbled by 54.93% to $676,000 in 2024, then spiked by 104.19% to $1.9 million in 2025.
  • Its Interest & Investment Income was $1.9 million in Q3 2025, compared to $2.0 million in Q2 2025 and $791,000 in Q1 2025.